Abstract:Five new ruthenium(II) polypyridyl complexes [Ru(N–N)2(BTCP)](ClO4)2 (BTCP = 2-(bicyclo[2.2.1]hept-5-en-2-yl)-1H-imidazo[4,5-f][1,10]phenanthroline; N–N = dmb: 4,4′-dimethyl-2,2′-bipyridine, 1; bpy: 2,2′-bipyridine 2; ttbpy: ditertairy-butyl-2,2′-bipyridine 3; phen: 1,10-phenanthroline 4; dmp: 2,9-dimethyl-1,10-phenanthroline 5) were synthesized and characterized by elemental analysis, IR, ESI-MS, 1H NMR and 13C NMR. The DNA-binding behaviors were studied by electronic absorption titration, viscosity measurements and molecular docking. The results show that complexes 1–4 interact with CT-DNA through intercalative modes, whereas complex 5 interacts through a partial intercalative mode. The DNA-binding constants follow the order of 3 > 4 > 1 > 2 > 5. The cytotoxic activity of the complexes against SGC-7901, PC-12, SiHa, HepG2, BEL-7402, A549 and HeLa cancer cell lines was evaluated by MTT method. The complexes display moderate cytotoxic activity toward BEL-7402 cells with an IC50 value of 25.5 ± 1.3 µM for 1, 45.7 ± 4.2 µM for 2, 6.5 ± 0.4 µM for 3, 13.2 ± 1.2 µM for 4 and 9.1 ± 1.1 µM for 5, respectively. Complex 5 exhibits the highest cytotoxic effect on the cell growth in SGC-7901, HepG2 and A549 cells among the complexes. The cytotoxic activity of the complexes is not consistent with the order of their DNA-binding constants. The apoptosis of BEL-7402 cells was studied under a fluorescent microscope and by flow cytometry. Measurements of reactive oxygen species, mitochondrial membrane potential and comet assays were carried out. The cell cycle arrest was investigated by flow cytometry, and the results demonstrate that complexes 1, 2, 4 and 5 inhibit the cell growth at G0/G1 phase and complex 3 induces cell cycle arrest at G2/M phase in BEL-7402 cells. The expression of Bcl-2 family induced by the complexes was studied by western blot. The results obtained show that complexes induce apoptosis in BEL-7402 cells through action of DNA and ROS-mediated mitochondrial dysfunction pathways.

Chiral Ruthenium(ii) Complexes with Phenolic Hydroxyl Groups As Dual Poisons of Topoisomerases I and IIα

Chiral Ruthenium(ii) Anthraquinone Complexes As Dual Inhibitors of Topoisomerases I and II

Dual Inhibition of Topoisomerases I and IIα by Ruthenium(ii) Complexes Containing Asymmetric Tridentate Ligands

Dual Topoisomerase I and II Poisoning by Chiral Ru(II) Complexes Containing 2-Thiophenylimidazo[4,5-f][1,10]phenanthroline Derivatives

Topoisomerase IIα Poisoning and DNA Double-Strand Breaking by Chiral Ruthenium(ii) Complexes Containing 2-Furanyl-imidazo[4,5-f][1,10]phenanthroline Derivatives.

Ruthenium(ii) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase.

Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes

Synthesis, DNA-binding and Topoisomerase Inhibitory Activity of Ruthenium(ii) Polypyridyl Complexes

Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis

Chiral Ruthenium(Ii) Polypyridyl Complexes: Stabilization of G-Quadruplex Dna, Inhibition of Telomerase Activity and Cellular Uptake

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Stabilization of G-quadruplex DNA, Inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(ii) Complexes.

Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights

Effect of Ancillary Ligands on the Topoisomerases Ii and Transcription Inhibition Activity of Polypyridyl Ruthenium(Ii) Complexes

Necroptosis Induced by Ruthenium(II) Complexes As Dual Catalytic Inhibitors of Topoisomerase I/II

Synthesis, Characterization, Cellular Uptake and Apoptosis-Inducing Properties of Two Highly Cytotoxic Cyclometalated Ruthenium(ii) Β-Carboline Complexes.

Mitochondria Are the Primary Target in the Induction of Apoptosis by Chiral Ruthenium(ii) Polypyridyl Complexes in Cancer Cells

Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.

Ruthenium (II) complexes containing a new asymmetric ligand: DNA interaction, photocleavage and topoisomerase i inhibition

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.